Entity

Wacker Biotech US specializes in the fermentative manufacture of pDNA. The company operates in San Diego as a CDMO and has a specialized, 650-liter-capacity fermentation line for the manufacture and purification of pDNA. Further, small-scale fermentation and downstream processing facilities for pDNA is scheduled to come on stream in late 2021. The company’s 40-plus employees have extensive experience in the production of pDNA aligned with the quality guidelines of Good Manufacturing Practice (GMP).